Winchester, United Kingdom

Andrew Gilbert Bright

This inventor holds 3 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignee: Pfizer Corporation. Active years: 2023-2026.

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2026

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Andrew Gilbert Bright

Introduction

Andrew Gilbert Bright is a notable inventor based in Winchester, GB. He has made significant contributions to the field of pharmaceuticals, holding a total of 3 patents. His work focuses on developing innovative aqueous formulations that are particularly suitable for intravenous or parenteral administration.

Latest Patents

Bright's latest patents include a pharmaceutical aqueous formulation comprising 1-(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea. This formulation is designed to be a clear solution, making it ideal for patient administration. Another patent involves a similar aqueous formulation that includes a pharmaceutically acceptable organic or inorganic acid salt, ensuring clarity and suitability for intravenous use.

Career Highlights

Andrew Gilbert Bright is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to focus on developing innovative solutions that address critical healthcare needs.

Collaborations

Bright collaborates with James Joseph Hussey, contributing to the advancement of pharmaceutical formulations and enhancing patient care through innovative research.

Conclusion

Andrew Gilbert Bright's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare solutions. His patents reflect a dedication to developing effective and safe formulations for patient use.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…